RUXOLITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10614PMP | RUXOLITINIB ruxolitinib 5 mg tablet, 56 (PI, CMI) |
2 | 112 | 0 | $4912.94 | $31.60 | $31.60 |
| Available brands | |||||||
| Jakavi |
RUXOLITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10615QMP | RUXOLITINIB ruxolitinib 15 mg tablet, 56 (PI, CMI) |
1 | 56 | 5 | $4912.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Jakavi |
RUXOLITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10616RMP | RUXOLITINIB ruxolitinib 5 mg tablet, 56 (PI, CMI) |
2 | 112 | 5 | $4912.94 | $31.60 | $31.60 |
| Available brands | |||||||
| Jakavi |
RUXOLITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10617TMP | RUXOLITINIB ruxolitinib 20 mg tablet, 56 (PI, CMI) |
1 | 56 | 5 | $4912.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Jakavi |
RUXOLITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10618WMP | RUXOLITINIB ruxolitinib 20 mg tablet, 56 (PI, CMI) |
1 | 56 | 0 | $4912.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Jakavi |
RUXOLITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10619XMP | RUXOLITINIB ruxolitinib 15 mg tablet, 56 (PI, CMI) |
1 | 56 | 0 | $4912.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Jakavi |
RUXOLITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10913JMP | RUXOLITINIB ruxolitinib 10 mg tablet, 56 (PI, CMI) |
1 | 56 | 0 | $4912.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Jakavi |
RUXOLITINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10927DMP | RUXOLITINIB ruxolitinib 10 mg tablet, 56 (PI, CMI) |
1 | 56 | 5 | $4912.93 | $31.60 | $31.60 |
| Available brands | |||||||
| Jakavi |
MOMELOTINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14743YMP | MOMELOTINIB Momelotinib 100 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $5800.71 | $31.60 | $31.60 |
| Available brands | |||||||
| Omjjara |
MOMELOTINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14744BMP | MOMELOTINIB Momelotinib 150 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $5800.71 | $31.60 | $31.60 |
| Available brands | |||||||
| Omjjara |
MOMELOTINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14762YMP | MOMELOTINIB Momelotinib 150 mg tablet, 30 (PI, CMI) |
1 | 30 | 0 | $5800.71 | $31.60 | $31.60 |
| Available brands | |||||||
| Omjjara |
MOMELOTINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14763BMP | MOMELOTINIB Momelotinib 200 mg tablet, 30 (PI, CMI) |
1 | 30 | 0 | $5800.71 | $31.60 | $31.60 |
| Available brands | |||||||
| Omjjara |
MOMELOTINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14769HMP | MOMELOTINIB Momelotinib 100 mg tablet, 30 (PI, CMI) |
1 | 30 | 0 | $5800.71 | $31.60 | $31.60 |
| Available brands | |||||||
| Omjjara |
MOMELOTINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14770JMP | MOMELOTINIB Momelotinib 200 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $5800.71 | $31.60 | $31.60 |
| Available brands | |||||||
| Omjjara |
- Legend
- MPMedical Practitioner




